SANTEN
Live / Registered — Registered (as of 08 Nov 2022)
What this means for you
Registered since 08 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88612394
- Registration number
- 6895659
- Mark type
- Stylized text
- Filed
- 11 Sept 2019
- Published for opposition
- 04 Aug 2020
- Registered
- 08 Nov 2022
- Attorney of record
- Michelle P. Ciotola
Goods and services
- Class 005 — Pharmaceuticals: eye drops; collyrium; ophthalmological preparations; pharmaceutical agents affecting sensory organs
Owner
- Santen Pharmaceutical Co., Ltd., Osaka, JP
- Santen Pharmaceutical Co., Ltd., Osaka, JP
- Santen Pharmaceutical Co., Ltd., Osaka, JP
Prior registrations
Prosecution history
- 08 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Sept 2022 — USE AMENDMENT FILED
- 05 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 07 Mar 2022 — ASSIGNED TO EXAMINER
- 09 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2022 — SOU EXTENSION 3 GRANTED
- 07 Feb 2022 — SOU EXTENSION 3 FILED
- 07 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 29 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Sept 2021 — SOU EXTENSION 2 GRANTED